1. Home
  2. THAR vs IPDN Comparison

THAR vs IPDN Comparison

Compare THAR & IPDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THAR
  • IPDN
  • Stock Information
  • Founded
  • THAR 2017
  • IPDN 2003
  • Country
  • THAR United States
  • IPDN United States
  • Employees
  • THAR N/A
  • IPDN N/A
  • Industry
  • THAR Biotechnology: Pharmaceutical Preparations
  • IPDN EDP Services
  • Sector
  • THAR Health Care
  • IPDN Technology
  • Exchange
  • THAR Nasdaq
  • IPDN Nasdaq
  • Market Cap
  • THAR 4.0M
  • IPDN 4.3M
  • IPO Year
  • THAR 2022
  • IPDN 2013
  • Fundamental
  • Price
  • THAR $1.25
  • IPDN $1.97
  • Analyst Decision
  • THAR Strong Buy
  • IPDN
  • Analyst Count
  • THAR 1
  • IPDN 0
  • Target Price
  • THAR $17.00
  • IPDN N/A
  • AVG Volume (30 Days)
  • THAR 135.2K
  • IPDN 36.7K
  • Earning Date
  • THAR 05-08-2025
  • IPDN 05-14-2025
  • Dividend Yield
  • THAR N/A
  • IPDN N/A
  • EPS Growth
  • THAR N/A
  • IPDN N/A
  • EPS
  • THAR N/A
  • IPDN N/A
  • Revenue
  • THAR N/A
  • IPDN $6,730,605.00
  • Revenue This Year
  • THAR N/A
  • IPDN N/A
  • Revenue Next Year
  • THAR N/A
  • IPDN N/A
  • P/E Ratio
  • THAR N/A
  • IPDN N/A
  • Revenue Growth
  • THAR N/A
  • IPDN N/A
  • 52 Week Low
  • THAR $1.20
  • IPDN $1.80
  • 52 Week High
  • THAR $7.13
  • IPDN $18.90
  • Technical
  • Relative Strength Index (RSI)
  • THAR 32.14
  • IPDN 40.12
  • Support Level
  • THAR $1.20
  • IPDN $2.40
  • Resistance Level
  • THAR $1.47
  • IPDN $2.59
  • Average True Range (ATR)
  • THAR 0.15
  • IPDN 0.21
  • MACD
  • THAR -0.01
  • IPDN 0.05
  • Stochastic Oscillator
  • THAR 2.04
  • IPDN 23.33

About THAR Tharimmune Inc.

Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset, known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.

About IPDN Professional Diversity Network Inc.

Professional Diversity Network Inc is engaged in providing access to networking, training, educational and employment services to its registered users. It has three operating segments: the Professional Diversity Network (PDN) segment, which includes online professional networking communities with career resources for diverse cultural groups and employers looking to hire members; and the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization, the RemoteMore segment. The company generates majority of its revenue from PDN Segment.

Share on Social Networks: